The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

Original article
Open Access

Effects of psilocybin therapy on personality structure

D. Erritzoe

Corresponding Author

E-mail address:d.erritzoe@imperial.ac.uk

Centre for Neuropsychopharmacology, Division of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK

David Erritzoe, Centre for Neuropsychopharmacology, Division of Brain Sciences, Department of Medicine, Imperial College London, Burlington Danes Building, Hammersmith Campus, 160 Du Cane Road, London W12 0NN, UK.

E‐mail: d.erritzoe@imperial.ac.uk

Search for more papers by this author
L. Roseman

Centre for Neuropsychopharmacology, Division of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK

Search for more papers by this author
M. M. Nour

South London and Maudsley NHS Foundation Trust, London, UK

The Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK

Search for more papers by this author
M. Kaelen

Centre for Neuropsychopharmacology, Division of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK

Search for more papers by this author
D. J. Nutt

Centre for Neuropsychopharmacology, Division of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK

Search for more papers by this author
R. L. Carhart‐Harris

Centre for Neuropsychopharmacology, Division of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK

Search for more papers by this author
First published: 19 June 2018

Abstract

Objective

To explore whether psilocybin with psychological support modulates personality parameters in patients suffering from treatment‐resistant depression (TRD).

Method

Twenty patients with moderate or severe, unipolar, TRD received oral psilocybin (10 and 25 mg, one week apart) in a supportive setting. Personality was assessed at baseline and at 3‐month follow‐up using the Revised NEO Personality Inventory (NEO‐PI‐R), the subjective psilocybin experience with Altered State of Consciousness (ASC) scale, and depressive symptoms with QIDS‐SR16.

Results

Neuroticism scores significantly decreased while Extraversion increased following psilocybin therapy. These changes were in the direction of the normative NEO‐PI‐R data and were both predicted, in an exploratory analysis, by the degree of insightfulness experienced during the psilocybin session. Openness scores also significantly increased following psilocybin, whereas Conscientiousness showed trend‐level increases, and Agreeableness did not change.

Conclusion

Our observation of changes in personality measures after psilocybin therapy was mostly consistent with reports of personality change in relation to conventional antidepressant treatment, although the pronounced increases in Extraversion and Openness might constitute an effect more specific to psychedelic therapy. This needs further exploration in future controlled studies, as do the brain mechanisms of postpsychedelic personality change.